Guidelines for the Diagnosis and Treatment of Parkinson’s Disease

Abstract

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).

Classification of extremity movements by visual observation of signals and their transforms

“…The incidence of PD, a condition afflicting 1% of people aged 60 years and older throughout the world, increases with age [1] . The evaluation of individuals with possible PD includes a comprehensive assessment of the medical and family histories, the physical and neurological examinations, and laboratory evaluations [2 , 3] . The administration of structured assessments to provide quantitative measurements constitutes a key component for the diagnosis and treatment of people with PD and related conditions.…”

Dataset of quality assurance measurements of rhythmic movements

“…Earlier versions of this work were presented at the International Congress of Parkinson's Disease and Movement Disorders, Madrid, Spain, September 15-18, 2022 [ 18 , 20 ], the Neurology Exchange Virtual Conference, September 20-22, 2022 [19] , the XXVIII IAPRD World Congress on Parkinson's Disease and Related Disorders, Chicago, USA, May 13-16, 2023 [ 36 , 37 ], and the 6 th World Parkinson Congress 2023 (WPC 2023), Barcelona, Spain, July 4-7, 2023 [38] , [39] , [40] , [41] .…”

Emerging role of immune therapy in treatment of neurodegenerative diseases

“…Dopaminergic agonists are also available since they can produce effects equal to dopamine. The next group of medications that can be used to stop the oxidative deamination of dopamine and stop dopamine depletion are monoamine oxidase inhibitors [15]. Besides, rivastigmine, donepezil, galantamine, clozapine, quetiapine, pimavanserin, and melatonin are used to address dementia, psychosis, and sleep-related symptoms [16].…”